Seqirus Holdings Australia Pty Ltd, a leading player in the biopharmaceutical industry, is headquartered in Australia and operates extensively across the Asia-Pacific region. Founded in 2015, Seqirus emerged from the merger of CSL Limited's influenza vaccine business and Novartis' influenza vaccine unit, marking a significant milestone in the global vaccine landscape. Specialising in the development and production of innovative vaccines, Seqirus is renowned for its commitment to public health, particularly in the field of influenza prevention. The company offers a diverse portfolio of products, including seasonal flu vaccines and pandemic response solutions, distinguished by their advanced technology and efficacy. With a strong market position, Seqirus has achieved notable recognition for its contributions to vaccine development and distribution, solidifying its role as a trusted partner in global health initiatives.
We don't have data for Seqirus Holdings Australia Pty Ltd, but we can show you information about their parent organization instead.
View parent company